JHVEPhoto / Shutterstock.com
27 March 2025NewsEuropeMarisa Woutersen

EU court signals tough stance on ‘pay-for-delay’ pharma deals

Advocate general recommends upholding €60.48 million fine against Teva and Cephalon for anti-competitive modafinil settlement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
19 October 2023   Luxemboug court agrees with European Commission that ‘beneficial arrangement’ between Teva and Cephalon delayed generic market entry of sleep disorder drug | Teva and subsidiary Cephalon to pay around €30m each plus costs.